These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 21262241)

  • 1. The role of neurexins in schizophrenia and autistic spectrum disorder.
    Reichelt AC; Rodgers RJ; Clapcote SJ
    Neuropharmacology; 2012 Mar; 62(3):1519-26. PubMed ID: 21262241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurexins.
    Reissner C; Runkel F; Missler M
    Genome Biol; 2013; 14(9):213. PubMed ID: 24083347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and characterization of copy number variation in autism spectrum disorder.
    Marshall CR; Scherer SW
    Methods Mol Biol; 2012; 838():115-35. PubMed ID: 22228009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copy-number variants in neurodevelopmental disorders: promises and challenges.
    Merikangas AK; Corvin AP; Gallagher L
    Trends Genet; 2009 Dec; 25(12):536-44. PubMed ID: 19910074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of neurexin 1beta signal peptide structural variants in patients with autism.
    Feng J; Schroer R; Yan J; Song W; Yang C; Bockholt A; Cook EH; Skinner C; Schwartz CE; Sommer SS
    Neurosci Lett; 2006 Nov; 409(1):10-3. PubMed ID: 17034946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autism spectrum disorder and genes for synaptic proteins].
    Shishido E
    Brain Nerve; 2012 Jan; 64(1):65-70. PubMed ID: 22223503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations affecting synaptic levels of neurexin-1β in autism and mental retardation.
    Camacho-Garcia RJ; Planelles MI; Margalef M; Pecero ML; Martínez-Leal R; Aguilera F; Vilella E; Martinez-Mir A; Scholl FG
    Neurobiol Dis; 2012 Jul; 47(1):135-43. PubMed ID: 22504536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of DNA copy number variation in schizophrenia.
    Tam GW; Redon R; Carter NP; Grant SG
    Biol Psychiatry; 2009 Dec; 66(11):1005-12. PubMed ID: 19748074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The possible interplay of synaptic and clock genes in autism spectrum disorders.
    Bourgeron T
    Cold Spring Harb Symp Quant Biol; 2007; 72():645-54. PubMed ID: 18419324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurexin 1alpha structural variants associated with autism.
    Yan J; Noltner K; Feng J; Li W; Schroer R; Skinner C; Zeng W; Schwartz CE; Sommer SS
    Neurosci Lett; 2008 Jun; 438(3):368-70. PubMed ID: 18490107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contact in the genetics of autism and schizophrenia.
    Burbach JP; van der Zwaag B
    Trends Neurosci; 2009 Feb; 32(2):69-72. PubMed ID: 19135727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic factors and epigenetic factors for autism: endoplasmic reticulum stress and impaired synaptic function.
    Momoi T; Fujita E; Senoo H; Momoi M
    Cell Biol Int; 2009 Dec; 34(1):13-9. PubMed ID: 20001973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurodevelopmental disturbance in the pathogenesis of major mental disorders].
    Kamiya A; Kitabatake Y; Sawa A
    Brain Nerve; 2008 Apr; 60(4):445-52. PubMed ID: 18421986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reelin glycoprotein: structure, biology and roles in health and disease.
    Fatemi SH
    Mol Psychiatry; 2005 Mar; 10(3):251-7. PubMed ID: 15583703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures.
    Lionel AC; Vaags AK; Sato D; Gazzellone MJ; Mitchell EB; Chen HY; Costain G; Walker S; Egger G; Thiruvahindrapuram B; Merico D; Prasad A; Anagnostou E; Fombonne E; Zwaigenbaum L; Roberts W; Szatmari P; Fernandez BA; Georgieva L; Brzustowicz LM; Roetzer K; Kaschnitz W; Vincent JB; Windpassinger C; Marshall CR; Trifiletti RR; Kirmani S; Kirov G; Petek E; Hodge JC; Bassett AS; Scherer SW
    Hum Mol Genet; 2013 May; 22(10):2055-66. PubMed ID: 23393157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurexin dysfunction in adult neurons results in autistic-like behavior in mice.
    Rabaneda LG; Robles-Lanuza E; Nieto-González JL; Scholl FG
    Cell Rep; 2014 Jul; 8(2):338-46. PubMed ID: 25017069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygous deletion of α-neurexin I or α-neurexin II results in behaviors relevant to autism and schizophrenia.
    Dachtler J; Ivorra JL; Rowland TE; Lever C; Rodgers RJ; Clapcote SJ
    Behav Neurosci; 2015 Dec; 129(6):765-76. PubMed ID: 26595880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autism: more evidence of a genetic cause].
    Bourgeron T; Leboyer M; Delorme R
    Bull Acad Natl Med; 2009 Feb; 193(2):299-304; discussion 304-5. PubMed ID: 19718887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reelin mutations in mouse and man: from reeler mouse to schizophrenia, mood disorders, autism and lissencephaly.
    Fatemi SH
    Mol Psychiatry; 2001 Mar; 6(2):129-33. PubMed ID: 11317213
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of neurexin 1 (NRXN1) polymorphisms in clozapine response.
    Souza RP; Meltzer HY; Lieberman JA; Le Foll B; Kennedy JL
    Hum Psychopharmacol; 2010 Nov; 25(7-8):582-5. PubMed ID: 20860064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.